Cells were grown in 96-well plates until 80% confluent, then serum-starved for 48 hours in 100 µl SFM. Cells were stimulated for 24 hours by adding 100 µl of agonists at 2x concentration diluted in SFM. Agonists were removed and replaced with 100 µl SFM containing 0.1 µCi/well methyl-[ 3 H]-thymidine (specific activity 1 µCi/µl, GE Healthcare) for 4 hours. Cells were washed twice with PBS before the addition of 0.2% Trypsin/PBS to each well. Plates were frozen overnight at -20 ºC, harvested onto 96 well filtermats using a cell harvester (Skatron Instruments) and scintillation counted using a MicroBeta TriLux workstation (Perkin Elmer). Data were collected as corrected counts per minute. Potential toxicity of signalling inhibitors was assessed using the CellTiter96®AqueousOneSolution Cell Proliferation Assay (MTS assay -Promega) according to manufacturer's instructions.
Real-time quantitative SYBR green RT-PCR
RNA was isolated using the RNeasy RNA isolation kit (Qiagen) and was DNase treated on the column using an RNase-free DNase set (Qiagen) according to manufacturer's instructions. DNase-treated total RNA (1 µg) was reverse transcribed to cDNA using an oligo dT primer (Roche) and MMLV-Reverse Transcriptase (Promega) according to manufacturer's instructions. PCR reactions were carried out using Quantitect SYBR green mastermix (Qiagen) according to manufacturer's instructions. Further details can be found in the supplementary data file. All reactions were performed using a Rotor-Gene 3000 machine (Corbett Research) using Rotor-Gene 5 software. Reactions were 10 µl containing 5 µl 2x SYBR green mastermix, forward and reverse primers (MWG Biotech, 500 nmol/l final concentration) and 1 µl cDNA. The following cycling parameters were used routinely: 95 ºC 15 min, then 40 cycles of 95 ºC 15 sec, 55 ºC 30 sec, 72 ºC 30 sec.
Melt-curve analysis following PCR showed a single product for all primers used.
Absolute copy number/µl cDNA for each gene of interest and the housekeeping gene GAPDH was calculated from a genomic DNA standard curve. Copy number was normalised by dividing copy number gene of interest by copy number GAPDH then expressed as a fold change over untreated. Primer sequences are shown in supplementary table 1.
Epiregulin detection by flow cytometry
CASMC were grown in T25 flasks, serum-starved for 48 hours then treated for the indicated times with PMA (200 nmol/l) or CX3CL1 (30 nmol/l) in SFM. Following treatment, cells were detached with PBS/EDTA (1:5000 w/v) for 15 mins on ice then CVR-2009-362R2 4 centrifuged at 1000 rpm for 5 mins at 4 ºC. Cells were then fixed for 10 mins on ice with 1% paraformaldehyde, washed with PBS, and permeabilised for 5 mins with 0.1% saponin/PBS then centrifuged at 1000 rpm for 5 mins at 4 ºC. Cells were re-suspended in blocking buffer (5% v/v FCS, 100 µg/ml human IgG, 0.1 % saponin, PBS) and blocked on ice for 10 mins. Cells were stained on ice for 30 mins with 5 µg/ml mouse anti-human epiregulin or isotype control (mouse IgG2B) before washing twice in 0.1% saponin / PBS. Cells were stained with anti-mouse PE secondary antibody at 1:200 for 30 mins on ice in the dark. Cells were washed twice in 0.1% saponin / PBS then resuspended for analysis by flow cytometry. Cells were initially gated on FSC/SSC to exclude cell debris then analysed for PE fluorescence in the FL2 channel.
Signalling assays
Serum-starved cells grown in 6-well plates were pre-treated ± antagonist for the indicated times before agonist addition. Media was removed and plates were frozen rapidly at -80 °C before the addition of lysis buffer (150 mmol/l NaCl, 0.8 mmol/l MgCl 2 , 5 mmol/l EGTA, 50 mmol/l HEPES, 1% NP-40, 1 mmol/l PMSF, 15 µg/ml leupeptin, 1 µmol/l pepstatin, 1 mmol/l Na 3 VO 4 ). Lysates were centrifuged at 18000 g for 10 mins at 4 °C and the supernatant collected. Protein concentrations were assayed using the BCA protein assay kit. 6 full-length fractalkine was monitored at a shear stress of 0.5 dynes cm 2 for 5 minutes and using DucoCell software to quantify cell numbers.
Supplementary

Supplementary Table 3: AZ12201182 selectivity for CX 3 CR1
Filtration radioligand binding assays were performed for CCR1 and CCR2 using membranes from HEK293S cells expressing the receptors and 125 I-MIP-1α and 125 I-MCP-1 respectively. Radioligand binding assays for CXCR2 were performed using SPA technology using membranes from HEK293S cells expressing the receptor, and 125 I-IL-8 as radioligand.
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